Drug–drug cocrystals of anticancer drugs erlotinib–furosemide and gefitinib–mefenamic acid for alternative multi-drug treatment
Author:
Affiliation:
1. Center for Materials Characterization
2. CSIR-National Chemical Laboratory
3. Pune
4. India
5. Academy of Scientific and Innovative Research (AcSIR)
6. Polymer Science and Engineering Division
Abstract
Drug–drug cocrystals of anticancer drugs erlotinib and gefitinib with furosemide and mefenamic acid, respectively, have been synthesized, characterized and their solubilities and dissolution rates were correlated with crystal structures.
Funder
Science and Engineering Research Board
Publisher
Royal Society of Chemistry (RSC)
Subject
Condensed Matter Physics,General Materials Science,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/CE/D0CE00353K
Reference36 articles.
1. Rationale and strategies for formulation development of oral fixed dose combination drug products
2. Fixed dose drug combinations (FDCs): rational or irrational: a view point
3. Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis
4. Triple fixed drug combinations in type 2 diabetes
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular structures of eight hydrogen bond-mediated minoxidil adducts from different aryl acids;Journal of Molecular Structure;2024-02
2. Selective Targeting of Lung Cancer Cells with Methylparaben-Tethered-Quinidine Cocrystals in 3D Spheroid Models;ACS Omega;2023-11-21
3. Polymorphism in Erlotinib Hydrochloride: New Insights into Relative Stability, Thermal Behavior, and Structural Differences of Forms A and B;Crystal Growth & Design;2023-08-29
4. Novel pharmaceutical co-crystals of gefitinib: synthesis, dissolution, cytotoxicity, and theoretical studies;CrystEngComm;2023
5. Cocrystallization of lenvatinib and temozolomide to improve the performance in terms of stability, dissolution, and tabletability;CrystEngComm;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3